Cytokeratin-18 (CK-18), a marker of apoptosis, also has potential value in differentiating NAFL from NASH and has a high specificity for NAFLD and fibrosis [30, 31]. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.